Navigation Links
Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
Date:5/14/2013

anitoba and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforcea
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... CytRx Corporation (Nasdaq: CYTR ), ... today announced that study designs and progress from two ... pivotal global Phase 3 clinical trial in relapsed/refractory soft ... trial in small cell lung cancer, will be presented ... Congress being held September 26-30, in Madrid, ...
(Date:9/22/2014)... Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or ... based on the number of directly operated stores, today ... Shareholders (the "AGM") on October 22, 2014 at 10:00 a.m. Beijing ... the Company at 6th Floor, Tower B, Xinnengyuan Building, Nanhai Road, ... 518054, People,s Republic of China . ...
(Date:9/20/2014)... OTTAWA , Sept. 20, 2014 /CNW/ - The issue: ... voluntarily recalling all lots of its Mylan-Nitro Spray 0.4 mg/metered ... is part of the pump component. A ... delivery of nitroglycerin to the patient. This defect may lead ... fact they are unable to access it. Not receiving nitroglycerin ...
Breaking Medicine Technology:CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 2CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 5CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 6China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2
... ALEXANDRIA, Va., March 1, 2012  The National Community ... campaign launched today by the Pharmaceutical Care Management ... (PBMs). (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... said NCPA Senior Vice President for Government Affairs John ...
... PARSIPPANY, N.J., March 1, 2012  PDI, Inc. (Nasdaq: ... its fourth quarter and full year 2011 financial results ... and host a conference call on Thursday, March 8, ... information: ,  Date:Thursday, March 8, 2012Time:8:30 am Eastern timeDial-in ...
Cached Medicine Technology:NCPA Blasts Irresponsible Ad by PBM Lobby as an Affront to Fighting Drug Diversion, Pharmacy Crime 2NCPA Blasts Irresponsible Ad by PBM Lobby as an Affront to Fighting Drug Diversion, Pharmacy Crime 3
(Date:9/22/2014)... (PRWEB) September 22, 2014 B. E. ... to healthcare providers, has been retained to lead a ... County-Benson Hospital (SCBH) in Benson, Minn. The top executive ... has recently placed more than 900 healthcare executives into ... serves the residents of Swift County, Benson and the ...
(Date:9/22/2014)... NY (PRWEB) September 22, 2014 ... Beth Schrope , NewYork-Presbyterian/Columbia University Medical Center ... islet surgery, to prevent diabetes in patients who ... first center in the New York metropolitan area ... roughly 87,000 people in the United States receive ...
(Date:9/22/2014)... September 22, 2014 The ... Winter & Alvin has just been released to ... the personal development community. The media attention surrounding ... HonestyFirstReviews.com's Tiffany Hendricks prompting an investigative review. , ... great interest for many entrepreneurs and others interested ...
(Date:9/22/2014)... September 22, 2014 Purchasing greenhouse starter ... helps ensure a positive outcome. Gothic Arch ... making them a leader in the industry and a ... , third generation owner of Gothic Arch Greenhouses, it’s ... needed. Warm, moist, controlled air created inside a greenhouse ...
(Date:9/22/2014)... 22, 2014 One key emerging trend ... are investing in R&D to develop new and advanced ... biomaterial implants. The introduction of third-generation orthopedic biomaterials such ... drugs will increase the growth of the market in ... Biomaterials market to grow at a CAGR of ...
Breaking Medicine News(10 mins):Health News:Swift County-Benson Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Swift County-Benson Hospital Retains B. E. Smith to Recruit New CEO 3Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 2Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 3Health News:"The Millionaire's Brain" - A Review Examining Winter & Alvin's Training Course Released 2Health News:Gothic Arch Greenhouses provides the Answers to the Many Questions and Considerations of Greenhouse Ownership 2Health News:Gothic Arch Greenhouses provides the Answers to the Many Questions and Considerations of Greenhouse Ownership 3Health News:Orthopedic Biomaterials Market to Grow at 10.78% CAGR by 2018, Forecasts a New Research Report at ReportsnReports.com 2Health News:Orthopedic Biomaterials Market to Grow at 10.78% CAGR by 2018, Forecasts a New Research Report at ReportsnReports.com 3Health News:Orthopedic Biomaterials Market to Grow at 10.78% CAGR by 2018, Forecasts a New Research Report at ReportsnReports.com 4
... have developed the first genetically altered monkey model that ... according to a new study funded by the National ... understand this complex, devastating and incurable genetic disorder affecting ... advance of online publication edition of Nature, could lead ...
... could offer therapy option for cancer patients ... medical techniques, it may be possible to create replacement ... to cancer. , That,s the conclusion of U.S. researchers ... Replacement bladders made from intestinal tissue have proven successful ...
... Men who come to the hospital with pneumonia generally are ... over the next year, despite aggressive medical care, according to ... International Conference of the American Thoracic Society. Scientific sessions are ... well known that women live longer than men. We have ...
... post-traumatic stress disorder (PTSD) among caregivers of deceased ... than in the average population, according to researchers ... well as their perceptions of the transplant recipients ... presented at the American Thoracic Societys 2008 International ...
... Study finds mortality and survival rates equal for both ... Minimally-invasive laparoscopic surgery and open surgery for colon cancer ... from 12 international studies involving over 3,300 patients. ... afraid that laparoscopy might impair survival in colorectal cancer ...
... aftermath of central China,s,earthquake, up to 50,000 people ... 150,000 were injured. An estimated 10 million people ... their homes. With great sorrow for,these widespread losses ... US$30,000, for a total of US$50,000. With contributions ...
Cached Medicine News:Health News:Researchers develop first transgenic monkey model of Huntington's disease 2Health News:Replacement Bladder Grown From Body's Own Cells 2Health News:Men at increased risk of death from pneumonia compared to women 2Health News:Depression and PTSD symptoms in caregivers of lung transplant patients 2Health News:Outcomes Similar for Laparoscopic, Open Colon Cancer Surgeries 2Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2
... Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope provides a new ... The latest in Fujinon engineering combines ... guide, and a wide 90 degree field ... distal tip diameter. In addition, the ...
... Tip Laryngoscopes are the most ... The articulating tip aids during ... improved view of epiglottis. Available ... styles. We guarantee your complete ...
German Style MacIntosh Fiber Optic Blade Laryngoscopes...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: